Convacell Vaccine（St Petersburg Research Institute of Vaccines and Sera）

N/A

Report date: 2023/02/14 20:00:43

Base Information

Drug NameConvacell Vaccine（St Petersburg Research Institute of Vaccines and Sera）

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus InfectionsRespiratory Tract Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryRussian Federation

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesSt Petersburg Research Institute of Vaccines and Sera

China Registration ClassN/A

Develop Information

Active CompaniesSt Petersburg Research Institute of Vaccines and Sera

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus InfectionsRespiratory Tract Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A